当前位置:首页 - 行情中心 - 博拓生物(688767) - 财务分析 - 现金流量表

博拓生物

(688767)

  

流通市值:54.63亿  总市值:54.63亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金344,518,448.03207,358,345.789,620,712.2465,654,975.3
  收到的税费返还22,715,618.4711,508,509.025,816,514.5451,382,689.18
  收到其他与经营活动有关的现金27,005,800.5518,130,392.1111,642,012.5956,986,608.13
  经营活动现金流入小计394,239,867.05236,997,246.83107,079,239.33574,024,272.61
  购买商品、接受劳务支付的现金172,996,079.75101,765,859.2663,686,666.69233,804,822.92
  支付给职工以及为职工支付的现金98,780,350.2769,185,873.7836,420,120.36123,291,462.65
  支付的各项税费11,861,287.312,856,525.9711,607,527.8421,075,653.74
  支付其他与经营活动有关的现金52,139,234.7745,074,616.6713,353,456.8989,384,232.86
  经营活动现金流出小计335,776,952.09228,882,875.68125,067,771.78467,556,172.17
  经营活动产生的现金流量净额58,462,914.968,114,371.15-17,988,532.45106,468,100.44
二、投资活动产生的现金流量:
  收回投资收到的现金2,906,900,0001,998,100,000908,500,0005,471,665,787.44
  取得投资收益收到的现金3,565,797.192,429,596.461,203,750.157,001,322.73
  处置固定资产、无形资产和其他长期资产收回的现金净额77,00022,090.91-2,741,395.44
  收到的其他与投资活动有关的现金331,372.34---
  投资活动现金流入小计2,910,874,169.532,000,551,687.37909,703,750.155,481,408,505.61
  购建固定资产、无形资产和其他长期资产支付的现金76,079,825.331,012,511.9922,534,904129,870,805.93
  投资支付的现金2,687,641,7131,752,896,511.81936,312,8805,219,834,232.16
  投资活动现金流出小计2,763,721,538.31,783,909,023.8958,847,7845,349,705,038.09
  投资活动产生的现金流量净额147,152,631.23216,642,663.57-49,144,033.85131,703,467.52
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,640,0002,640,0002,640,000-
  其中:子公司吸收少数股东投资收到的现金2,640,0002,640,0002,640,000-
  取得借款收到的现金100,000,000100,000,000--
  收到其他与筹资活动有关的现金-0-3,147,500
  筹资活动现金流入小计102,640,000102,640,0002,640,0003,147,500
  偿还债务支付的现金477,187.98477,187.98--
  分配股利、利润或偿付利息支付的现金105,131,162.59104,673,333.8-159,875,000.5
  支付其他与筹资活动有关的现金119,642,812.02110,642,812.02-1,329,402.64
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计225,251,162.59215,793,333.8-161,204,403.14
  筹资活动产生的现金流量净额-122,611,162.59-113,153,333.82,640,000-158,056,903.14
四、汇率变动对现金及现金等价物的影响-43,447,235.84-32,503,908.83-17,537,266.19-12,677,811.46
五、现金及现金等价物净增加额39,557,147.7679,099,792.09-82,029,832.4967,436,853.36
  加:期初现金及现金等价物余额1,171,196,284.521,171,196,284.521,171,196,284.521,103,759,431.16
  期末现金及现金等价物余额1,210,753,432.281,250,296,076.611,089,166,452.031,171,196,284.52
补充资料:
  净利润--17,094,519.68-47,126,834.92
  资产减值准备-1,959,553.85-5,763,033.17
  固定资产和投资性房地产折旧-11,700,129.27-23,314,377.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,700,129.27-23,314,377.73
  无形资产摊销-2,761,745.35-955,984.56
  处置固定资产、无形资产和其他长期资产的损失-8,531.25--247,488.75
  固定资产报废损失-106,444.85-42,136.44
  公允价值变动损失--353,518.3--320,319.1
  财务费用-36,501,746.79-12,975,556.21
  投资损失-1,554,820.42--3,969,405.85
  递延所得税--6,632,830.05-1,696,537.09
  其中:递延所得税资产减少--6,632,830.05-1,696,537.09
  存货的减少--2,007,190.92--2,042,273.7
  经营性应收项目的减少--4,961,033.61-3,785,137.83
  经营性应付项目的增加--16,350,241.78-8,842,273.47
  其他-102,544.68-8,782,558.19
  现金的期末余额-1,250,296,076.61-1,171,196,284.52
  减:现金的期初余额-1,171,196,284.52-1,103,759,431.16
  现金及现金等价物的净增加额-79,099,792.09-67,436,853.36
公告日期2026-10-302026-08-292026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑